Morabito, Gabriella
Gregorio, Caterina
Ieva, Francesca
Barbati, Giulia
Mancia, Giuseppe
Corrao, Giovanni
Rea, Federico
Article History
Received: 30 January 2024
Accepted: 3 July 2024
First Online: 6 July 2024
Declarations
:
: This study followed the principles of the Declaration of Helsinki. Data used in this study were anonymized before its use. According to Italian law, studies based entirely on registry data are exempt from patients informed consent and do not require approval from an ethics review board (General Authorization for the Processing of Personal Data for Scientific Research Purposes Issued by the Italian Privacy Authority on August 10, 2018; ).
: Not applicable.
: GC received research support from the European Community (EC), the Italian Agency of Drug (AIFA), and the Italian Ministry of Education, University and Research (MIUR). He took part to a variety of projects that were funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN, BMS and Servier). He also received honoraria as member of Advisory Board from Roche. GM2 received honoraria for participation as speaker/chairman in national/international meetings from Bayer, Boehringer Ingelheim, CVRx, Daiichi Sankyo, Ferrer, Medtronic, Menarini Int., Merck, Novartis, Recordati and Servier.Other authors declare that they have no competing interests.